Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Feb 17, 2011
Stephen Friend just might revolutionize the pharmaceutical industry. After founding Rosetta Inpharmatics, Stephen served as Merck's senior vice president of cancer research. In 2009, he left Merck to create Sage Bionetworks, a nonprofit biomedical research organization. From there, Stephen hopes to create a commons for commercial biomedical researchers.